4-hexylresorcinol stimulates the differentiation of SCC-9 cells through the suppression of E2F2, E2F3 and Sp3 expression and the promotion of Sp1 expression

Kim,Seong-Gon; Kim,An-Sook; Jeong,Jae-Hwan; Choi,Je-Yong; Kweon,HaeYong

doi:10.3892/or.2012.1845

4-hexylresorcinol stimulates the differentiation of SCC-9 cells through the suppression of E2F2, E2F3 and Sp3 expression and the promotion of Sp1 expression

Authors:
- Seong-Gon Kim
- An-Sook Kim
- Jae-Hwan Jeong
- Je-Yong Choi
- HaeYong Kweon
View Affiliations

Affiliations: Department of Oral and Maxillofacial Surgery, College of Dentistry, Gangneung-Wonju National University, Gangneung 210-702, Republic of Korea, Department of Dentistry, Hallym University, Chuncheon 200-702, Republic of Korea, Department of Biochemistry and Cell Biology, WCU Program, CMRI, Skeletal Diseases Genome Research Center, School of Medicine, Kyungpook National University, Daegu 700-422, Republic of Korea, National Academy of Agricultural Science, RDA, Suwon 441-707, Republic of Korea
Published online on: June 1, 2012 https://doi.org/10.3892/or.2012.1845
Pages: 677-681

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The dormancy-inducing factors of bacteria inhibit tumor cell growth. In the present study, we evaluated the antitumor effects of the dormancy-inducing factor 4-hexylresorcinol (4-HR) using real-time cell electronic sensing (RT-CES) in SCC-9 cells (tongue squamous cell carcinoma cells). Treatment with 4-HR suppressed the growth of SCC-9 cells in a dose-dependent manner. We used a DNA microarray to identify genes that showed a significant change in expression upon 4-HR administration in SCC-9 cells. Among the differentially expressed genes, the protein expression of several cell proliferation related factors, including E2F1, E2F2, E2F3, E2F4, E2F5, E2F6, Sp1 and Sp3, were determined by western blot analyses. Treatment with 4-HR strongly suppressed E2F2 and slightly suppressed E2F3 but did not change the expression of E2F1, E2F4, E2F5 and E2F6 relative to no treatment. Furthermore, 4-HR increased Sp1 expression in a dose-dependent manner and decreased Sp3 expression. Therefore, the ratio of Sp1 to Sp3, an important driving force of epithelial cell differentiation, was drastically increased. Consistent with this observation, 4-HR increased the expression of the epithelial cell differentiation markers involucrin and keratin 10. Together, our results indicate that 4-HR induces the differentiation of SCC-9 via the modulation of the E2F-mediated signaling pathway.

View Figures

View References

1	Wong CF, Barnes LM, Dahler AL, et al: E2F suppression and Sp1 overexpression are sufficient to induce the differentiation-specific marker, transglutaminase type 1, in a squamous cell carcinoma cell line. Oncogene. 24:3525–3534. 2005. View Article : Google Scholar : PubMed/NCBI
2	Bruckman KC, Schönleben F, Qiu W, Woo VL and Su GH: Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 110:632–637. 2010. View Article : Google Scholar : PubMed/NCBI
3	Wong CF, Barnes LM, Dahler AL, et al: E2F modulates keratinocyte squamous differentiation: implications for E2F inhibition in squamous cell carcinoma. J Biol Chem. 278:28516–28522. 2003. View Article : Google Scholar : PubMed/NCBI
4	Wong CF, Barnes LM, Smith L, Popa C, Serewko-Auret MM and Saunders N: E2F6: a member of the E2F family that does not modulate squamous differentiation. Biochem Biophys Res Commun. 324:497–503. 2004. View Article : Google Scholar : PubMed/NCBI
5	Polyak K, Kato JY, Solomon MJ, et al: p27^Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. J Gene Dev. 8:9–22. 1994.
6	DeGregori J, Kowalik T and Nevins JR: Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol. 15:4215–4224. 1995.PubMed/NCBI
7	DeGregori J, Leone G, Miron A, Jakoi L and Nevins JR: Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci USA. 94:7245–7250. 1997. View Article : Google Scholar : PubMed/NCBI
8	Wu L, Timmers C, Maiti B, et al: The E2F1-3 transcription factors are essential for cellular proliferation. Nature. 414:457–462. 2001. View Article : Google Scholar : PubMed/NCBI
9	Wu Z, Zheng S and Yu Q: The E2F family and the role of E2F1 in apoptosis. Int J Biochem Cell Biol. 41:2389–2397. 2009. View Article : Google Scholar : PubMed/NCBI
10	Wang J, Helin K, Jin P and Nadal-Ginard B: Inhibition of in vitro myogenic differentiation by cellular transcription factor E2F1. Cell Growth Differ. 6:1299–1306. 1995.PubMed/NCBI
11	Guy CT, Zhou W, Kaufman S and Robinson MO: E2F-1 blocks terminal differentiation and causes proliferation in transgenic megakaryocytes. Mol Cell Biol. 16:685–693. 1996.PubMed/NCBI
12	Fajas L, Landsberg RL, Huss-Garcia Y, Sardet C, Lees JA and Auwerx J: E2Fs regulate adipocyte differentiation. Dev Cell. 3:39–49. 2002. View Article : Google Scholar : PubMed/NCBI
13	Kozubek A and Tyman JHP: Resorcinolic lipids, the natural non-isoprenoid phenolic amphiphiles and their biological activity. Chem Rev. 99:1–25. 1999. View Article : Google Scholar : PubMed/NCBI
14	Mutoh M, Takahashi M, Fukuda K, et al: Suppression of cyclooxygenase-2 promoter-dependent transcription activity in colon cancer cells by chemopreventive agents with a resorcin-type structure. Carcinogenesis. 21:959–963. 2000. View Article : Google Scholar : PubMed/NCBI
15	Hasegawa R, Furukawa F, Toyoda K, et al: Inhibitory effect of antioxidants on N-bis(2-hydroxypropyl)nitrosamine-induced lung carcinogenesis in rats. Jpn J Cancer Res. 81:871–877. 1990. View Article : Google Scholar : PubMed/NCBI
16	Maruyama H, Amamura T, Nakae D, et al: Effect of catechol and its analogs on pancreatic carcinogenesis initiated by N-nitrosobis(2-oxopropyl)amine in Syrian hamsters. Carcinogenesis. 12:1331–1334. 1991. View Article : Google Scholar : PubMed/NCBI
17	Kim SG, Jeong JH, Park YW, et al: 4-Hexylresorcinol inhibits transglutaminase-2 activity and has synergistic effects along with cisplatin in KB cells. Oncol Rep. 25:1597–1602. 2011.PubMed/NCBI
18	Kim SG, Lee SW, Park YW, Jeong JH and Choi JY: 4-hexylresorcinol inhibits NF-κB phosphorylation and has a synergistic effect with cisplatin in KB cells. Oncol Rep. 26:1527–1532. 2011.PubMed/NCBI
19	Kim JY, Choi JY, Jeong JH, et al: Low molecular weight silk fibroin increases alkaline phosphatase and type I collagen expression in MG63 cells. BMB Rep. 43:52–56. 2010. View Article : Google Scholar : PubMed/NCBI
20	Trollinger DR, Cascio WE and Lemasters JJ: Selective loading of Rhod 2 into mitochondria shows mitochondrial Ca²⁺ transients during the contractile cycle in adult rabbit cardiac myocytes. Biochem Biophy Res Commun. 236:738–742. 1997. View Article : Google Scholar : PubMed/NCBI
21	Wagenblast J, Baghi M, Arnoldner C, et al: Effect of bortezomib and cetuximab in EGF-stimulated HNSCC. Anticancer Res. 28:2239–2243. 2008.PubMed/NCBI
22	Braig M, Lee S, Loddenkemper C, et al: Oncogene-induced senescence as an initial barrier in lymphoma development. Nature. 436:660–665. 2005. View Article : Google Scholar : PubMed/NCBI
23	Chen Z, Trotman LC, Shaffer D, et al: Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature. 436:725–730. 2005. View Article : Google Scholar : PubMed/NCBI
24	Michaloglou C, Vredeveld LC, Soengas MS, et al: BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature. 436:720–724. 2005. View Article : Google Scholar : PubMed/NCBI
25	Hazar-Rethinam M, Cameron SR, Dahler AL, et al: Loss of E2F7 expression is an early event in squamous differentiation and causes derepression of the key differentiation activator Sp1. J Invest Dermatol. 131:1077–1084. 2011. View Article : Google Scholar : PubMed/NCBI
26	Muller H, Bracken AP, Vernell R, et al: E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 15:267–285. 2001. View Article : Google Scholar : PubMed/NCBI
27	Dicker AJ, Popa C, Dahler AL, et al: E2F-1 induces proliferation-specific genes and suppresses squamous differentiation-specific genes in human epidermal keratinocytes. Oncogene. 19:2887–2894. 2000. View Article : Google Scholar